• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, April 6, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New study suggests ovarian hormone may make drug withdrawal symptoms worse for women

Bioengineer by Bioengineer
June 18, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(Carlisle, Pa.) – New research published in the journal Neuroscience Letters suggests women may have more difficulty than men in withdrawing from and staying off methamphetamine. The study by Dickinson College neuroscientists looked at the interaction of estradiol–a naturally occurring form of estrogen and the major female sex hormone–and methamphetamine in female mice. Researchers found estradiol could contribute to anxiety-like behavior in the mice as they withdrew from the drug. These observations indicate the hormone may contribute to drug relapse in women by worsening anxiety-related symptoms during withdrawal.

"We tend to think of methamphetamine use disorder as a traditionally male problem, but women experience it differently, and this hormone may be a factor in that experience," said research co-author Anthony Rauhut, associate professor of psychology at Dickinson. The finding supports previous studies, which have found women are more likely than men to initiate methamphetamine use earlier, escalate to regular use in a shorter period of time and show signs of greater dependency. Previous research also has found women are more prone to use methamphetamine while also experiencing psychiatric disorders, like anxiety.

"The level of ovarian hormones circulating in a woman's bloodstream fluctuates throughout her menstrual cycle," said study co-author Meredith Curran-Rauhut, neuroscience instructor at Dickinson. "This research suggests that fluctuating estradiol levels may impact severity of withdrawal symptoms in women."

In order to control hormone levels, researchers performed an ovariectomy on mice involved in the study. One group received an implanted estradiol capsule. When injected with methamphetamine, these mice exhibited more anxiety-like behavior as they withdrew from the drug than the mice who did not receive the hormone implant.

"Mouse anxiety behavior is well-understood from decades of observation," explained Rauhut. "Certain measurable behaviors, like how far a mouse travels during its time in the test field or how much time it spends resting along the sides of the chamber can tell us how anxious the animal is."

The husband-and-wife research team thinks their study could lead to further work on women and drug addiction, including studying whether exercise plays a role in reducing the negative effects of drug withdrawal. "The medical field needs to differentiate better between women and men, especially in addiction treatment," Curran-Rauhut said.

###

Media Contact

Craig Layne
[email protected]
814-397-6264
@DickinsonCol

http://www.dickinson.edu

http://dx.doi.org/10.1016/j.neulet.2018.05.025

Share12Tweet8Share2ShareShareShare2

Related Posts

Emergency Room Screening Tool Accurately Identifies Firearm Violence Risk in Young Adults

April 6, 2026

Scientists Discover Blood Biomarker Linked to Cancer Risk in Lynch Syndrome Patients

April 6, 2026

Advances in Modeling ATP13A2-Related Neurodegeneration

April 6, 2026

Cognitive Changes Over Time in Parkinson’s Disease

April 6, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    97 shares
    Share 39 Tweet 24
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1009 shares
    Share 399 Tweet 249
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Researchers Uncover Mechanisms of Key Immune Cells in Prostate Protection

Vanderbilt Center for Antibody Therapeutics Partners to Develop Novel Anti-Measles Antibody Treatment

Emergency Room Screening Tool Accurately Identifies Firearm Violence Risk in Young Adults

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.